Pharmoduct is an automated and patented device for the sterile preparation of personalised oncology drugs, including chemotherapy and biologicals.
Pharmoduct is able to reconstitute, transfer and dilute oncology drugs in order to prepare final doses (patient specific) and multi-dose bags (pharmacy bulk package). The system can manage more than 300 different drugs.
The introduction of Pharmoduct in the Compounding Lab will improve the whole oncology drugs preparation workflow.
Automatic Compounding System for Oncology Drugs
Patented Class I Medical Device
Liquid and powder drug management
Final bags and multi – dose bags preparation
Performance: Syringes 35/h – IV bags 25/h – Elastomeric pumps 20/h
Dose accuracy – ± 5%
Main components
1 - Automatic ozone cleaning system
2 - Negative pressure LAF with ULPA-U15 filters
3 - 15” touch screen monitor
4 - Thermal transfer printer for personalized labels
5 - Barcode identification system for diluent kit
6 - RFID identification system with integrated scale for consumable kits
7 - Upper rotating assembly for drug vials
8 - Label identification system for vials
9 - Gravimetric scale for multidose bag
10 - Peristaltic pumps for liquid transfer
11 - Lower rotating assembly for final containers
12 - Segregated waste area with bag heat sealing
Final containers (all brands)
Syringes – up to 60 ml
IV bags – up to 1000 ml
Elastomeric pumps/infusors – up to 300 ml
Bottles – up to 500 ml
Other containers (with LL connection)
Multi-dose bags
Multi-dose bags – up to 2000 ml
Drug source
Vials (ISO 13/ISO 20)– up to 100 ml
Multidose bags (filled by Pharmoduct or available on the market) – up to 2000 ml